Goodwin Biotechnology Inc. Completes cGMP Manufacturing of AREVA Med's Conjugate
September 14, 2009 08:00 ET
|
Goodwin Biotechnology Incorporated
PLANTATION, Fla., Sept. 14, 2009 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) announced today the completion of the cGMP manufacturing and vialing of AREVA Med's monoclonal antibody-chelator...
Goodwin Biotechnology Inc. Completes Development of AREVA's New Cancer Treatment
December 12, 2008 07:00 ET
|
Goodwin Biotechnology Incorporated
PLANTATION, Fla., Dec. 12, 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) announced today the successful completion of the development work for the new AREVA drug that will be radio-labeled...
Goodwin Biotechnology Inc. beendet Entwicklung von AREVAs neuer Krebsbehandlung
December 12, 2008 07:00 ET
|
Goodwin Biotechnology Incorporated
PLANTATION, Fla., 12. Dez. 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc.
(GBI) hat heute die erfolgreiche Beendigung der Entwicklungsarbeit für das neue
AREVA Medikament bekannt gegeben, das...
Goodwin Biotechnology Inc. achève le développement du nouveau traitement contre le cancer d'AREVA
December 12, 2008 07:00 ET
|
Goodwin Biotechnology Incorporated
Goodwin Biotechnology Inc. achève le développement du nouveau traitement contre
le cancer d'AREVA
PLANTATION, Floride, le 12 décembre 2008 (GLOBE NEWSWIRE) -- Goodwin
Biotechnology Inc. (GBI)...
Goodwin Biotechnology Inc. Completes Development of AREVA's New Cancer Treatment
December 12, 2008 07:00 ET
|
Goodwin Biotechnology Incorporated
PLANTATION, Fla., Dec. 12, 2008 (GLOBE NEWSWIRE) -- Goodwin Biotechnology Inc.
(GBI) announced today the successful completion of the development work for the
new AREVA drug that will be...
Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used in Successful Melanoma Trial
July 21, 2008 07:00 ET
|
Goodwin Biotechnology Incorporated
PLANTATION, Fla., July 21, 2008 (PRIME NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) today announced that the melanin-binding IgM antibody manufactured by the company was used in a successful Phase I...
AREVA Selects Goodwin Biotechnology Inc. As a Partner for Its New Cancer Treatment
June 30, 2008 07:00 ET
|
Goodwin Biotechnology Incorporated
PLANTATION, Fla., June 30, 2008 (PRIME NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) disclosed today that it has begun process development toward AREVA's lead-212 initiative to treat cancer. As part...